Flow Cytometry Market Research Report by Component (Cytometry Platform [Cell Sorters, Cell Analyzers], Accessories [Filter, Laser, Detectors], Reagents and Consumables [Antibodies, Dyes, Beads, Solution, Buffer], Software, and Services), by Technology (Bead Based Flow Cytometry and Cell Based Flow Cytometry) by Application (Academic and Clinical Research Applications [Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others] and Diagnosis Applications [Cancer {Leukemia, Lymphoma,

Global Flow Cytometry Market Overview

The Flow Cytometry Market size was valued at USD 5.49 billion in 2023 and projected to grow from USD 5.96 billion in 2024 to USD 11.42 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.49% during the forecast period (2024 - 2032).

The factors that are driving the growth of the global market are the increasing prevalence of chronic diseases and growing demand for point-of-care testing.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

In March 2024, Beckman Coulter Life Sciences, a subsidiary of Danaher Corporation and a prominent player in laboratory automation and innovation, remains at the forefront of the industry by introducing the CytoFLEX nano Flow Cytometer. This cutting-edge device, designed specifically for research purposes, is the first of its kind to enable detection at a minimum of 40 nm. As a result, it allows for the generation of 30-50% more data compared to existing options available in the market. The CytoFLEX nano Flow Cytometer is an analytical instrument that has exceptional sensitivity in detecting, counting, and characterizing nanoparticles. It is capable of simultaneous multiparameter detection using six fluorescent detection channels and five side scatter channels. The answer offered by this technology is unique in global laboratories as it reduces the minimum detectable amount and improves the ability to identify less common targets in a diverse population of extracellular vesicles (EVs) ranging from 1 μm to 40 nm (specifically, when using violet side scatter as a trigger). The CytoFLEX micro Flow Cytometer surpasses the prior constraints of detection capabilities, equipping researchers with data that was previously inaccessible to them.

Flow Cytometry Market Trends

• Increasing prevalence of chronic diseases

There has been a significant increase in the prevalence of chronic diseases such as cancer, cardiovascular diseases, autoimmune diseases, infectious diseases, and others which has led to an increased demand for advanced diagnostic and research tools such as flow cytometry. For instance, according to World Health Organization (WHO) figures, cancer is the primary or second leading cause of death in 112 of 183 nations before the age of 70. Similarly, GLOBOCAN 2020 estimates of cancer incidence produced by the International Agency for Research on Cancer state worldwide, an estimated 19.3 million new cancer cases in 2020. Additionally, according to the WHO, in 2019, an estimated 17.9 million individuals died from cardiovascular diseases, accounting for 32% of all global deaths. 85% of these deaths were caused by a heart attack. Flow cytometry, with its capability to study specific cell populations and analyze immune responses, has become indispensable in comprehending the complex cellular mechanisms underlying chronic diseases. It allows researchers and clinicians to identify biomarkers, analyze disease progression, and monitor treatment response at a cellular level. As a result, the need for efficient and high-throughput flow cytometry systems has increased, propelling the market growth.

Furthermore, the increasing demand for point-of-care testing (POCT) has been a major driver of the flow cytometry market. POCT refers to diagnostic testing performed at or near the patient's location, providing rapid and immediate results. In this context, flow cytometry has gained prominence due to its ability to deliver real-time, high-throughput analysis of individual cells, making it a valuable tool for decentralized diagnostic settings.

As a result of the growing burden of chronic diseases and the shift toward decentralized diagnostics, flow cytometry has an exciting prospect as a key player in the fight against these complex medical challenges.

Flow Cytometry Market Segment Insights

Flow Cytometry Component Insights

Based on component, the Flow Cytometry Market is segmented into cytometry platform, accessories, reagents and consumables, software, and services. Further, the cytometry platform has been bifurcated into cell sorters and cell analyzers; accessories have been further segmented into filter, laser, detectors, and others; and reagents and consumables have been segmented into antibodies, dyes, beads, solution, buffer, and others. The cytometry platform held the largest market share in 2022, and the reagents and consumables segment is anticipated to register the highest CAGR from 2022 to 2032. Cytometry platforms offer a plethora of advantages across various research and clinical applications, making them invaluable tools in modern medicine and biology. The advantages include high-throughput analysis, multiparameter analysis, sensitivity and specificity, functional assays, single-cell resolution, and point-of-care potential. Furthermore, the factors that are contributing to the component growth are the rise of chronic diseases and the promise of personalized medicine.

Flow Cytometry Technology Insights

Based on technology, the Flow Cytometry Market has been segmented into bead based flow cytometry and cell based flow cytometry. Cell based flow cytometry held the largest market share in 2022 and bead based flow cytometry is anticipated to register the highest CAGR from 2022 to 2032. Bead based flow cytometry is a powerful technology that utilizes antibody-coated beads to identify and analyze specific cell populations within a sample. This technology is primarily utilized in cancer research and stem cell research. Furthermore, cell-based flow cytometry is a technology that uses lasers and fluorescent dyes to analyze individual cells as they flow through a single file stream. This technology is utilized in drug discovery for screening drug candidates and immunology to study immune cell activation and differentiation.

Hence, the wide range of applications of bead based flow cytometry and cell based flow cytometry is driving the growth of the technology segment.

FIGURE 2: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023 & 2032 (USD BILLION)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Flow Cytometry Application Insights

Based on application, the flow cytometry market is segmented into academic and clinical research applications and diagnosis applications. Academic and clinical research applications further segmented into cell cycle analysis and cell proliferation, apoptosis, sorting and screening, transfection and cell viability, others and diagnosis applications segmented into cancer immunodeficiency diseases, organ transplantation, and others. The cancer segment divided into leukemia, lymphoma, and others. Diagnostic applications segment held the largest market in 2022 and is register the highest CAGR during the forecast period. One of the main drivers of the Flow Cytometry Market expansion is the rise in cancer and immune diseases. According to the World Health Organization, cancer was the leading cause of death in 2020 across the world and the most common cancer reported with breast, colon, rectum, and prostate. Hence, the increasing demand for flow cytometry products owing to the rise in cancer and other chronic diseases is driving the market for the application segment.

Flow Cytometry End User Insights

Based on end user, the flow cytometry market is segmented into hospitals & clinics, commercial organizations, medical schools and clinical labs, research institutes, and others. Hospitals & clinics held the largest market share in 2022 and commercial organizations is anticipated to register the highest CAGR during the forecast period. The growing demand for flow cytometry in hospitals and clinics reflects its evolving role in modern healthcare. It has transitioned from a primarily research tool to a valuable diagnostic and clinical asset, aiding in precise diagnosis, personalized treatment, and improved patient care for a wide range of chronic and complex diseases.

Flow Cytometry Regional Insights

By region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest market share of over 39.56% in 2022 due to its high deployment of scientifically advanced flow cytometry technologies, large healthcare spending, and well-established healthcare infrastructure in the region. Moreover, the fact that Canada has a high number of human immunodeficiency virus (HIV) cases contributes to the expansion of the flow cytometry market. As per the Government of Canada there were an estimated 62,790 persons in Canada were living with HIV from 2020 to 2021.

Further, the major countries studied are: The US, Canada, Brazil, Germany, France, the UK, Italy, Spain, China, India, Japan, South Korea, and Australia.

FIGURE 3: FLOW CYTOMETRY MARKET, BY REGION, 2023 & 2032 (USD BILLION)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe flow cytometry market shows significant growth during the forecast year, i.e., 2024–2032, owing to the rising chronic illness prevalence, increasing need for new technologies in the flow cytometry industry, which increases demand, and rising investment in research & development, which leads to market expansion. Furthermore, the pandemic has fueled innovation in the flow cytometry space, as indicated by the introduction of new products in this field. For instance, in July 2021, Eurofins Viracor, Inc. (Luxembourg), launched its Coronavirus SARS-CoV-2 inSIGHT T Cell Immunity testing platform. The test uses flow cytometry to provide critical information about a patient's reaction to COVID-19 antigens, which aids in making appropriate treatment decisions. Furthermore, the Germany flow cytometry market held the largest market share in 2022 and Italy flow cytometry market is the fastest growing market in the Europe region.

The Asia-Pacific flow cytometry market is the fastest-growing region as a result of the expanding pharmaceutical and biotechnology industries in rising economies such as China and India. China's rising research contributions are due to the trend of cytometry science and technology being a frontier multidisciplinary research topic, attracting a lot of research attention from both academia and industry. Moreover, in Australia, research and development initiatives continue to grow. Scientists and researchers in the country are often conducting diagnostic tests and doing groundbreaking research to develop advancements. Furthermore, China flow cytometry market held the largest market share in 2022 and India flow cytometry market is the fastest growing market in the Asia-Pacific region.

Analyst Comment

“The global functional service providers (FSP) market is thriving, fueled by the brisk biopharmaceutical and biotechnology sectors. Rising R&D investments, in addition to the increasing complexity and cost of clinical trials, have created an ideal setting for FSPs to flourish.”

Flow Cytometry Key Market Players & Competitive Insights

The Flow Cytometry Market is extremely competitive, with players competing, partnering, and investing heavily in research and development to gain a significant market share. The market is moderately fragmented with rising competition, product launches, increasing collaborative partnerships, and other strategic decisions to achieve operational efficiency.

The business model developed by manufacturers in the Flow Cytometry Market includes manufacturing high-quality flow cytometry products. Mergers and collaborations were also observed to expand the company's product portfolio, as well as introduce new products. The growth of prominent industry players is dependent on various factors, such as market conditions, government support, and industry development. Key manufacturers in the flow cytometry market are focusing on developing products with advanced technologies. It is also projected that increasing government funding for medical education institutes will also boost the market's growth in the upcoming future.

Thermo Fisher Scientific, Inc. (US) specializes in various biotechnology products such as laboratory supply chain programmes, analytical instruments, e-commerce, laboratory equipment, specialty diagnostics, and lab services. It helps its customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to the market, and increase the productivity of the laboratory. It has a presence in the Americas, Asia-Pacific, Europe, the Middle East, and Africa. Moreover, in October 2022, Thermo Fisher Scientific, Inc.'s subsidiary, namely PPD (US), invested approximately USD 59 million in order to expand its laboratory operations in Highland Heights, Kentucky, US. The Highland Heights central Lab along with other safety includes flow cytometry.

Key Companies in the Flow Cytometry Market includes.

• Thermo Fisher Scientific, Inc. (US)


• Beckman Coulter, Inc. (US)


• Agilent Technologies, Inc. (US)


• Sartorius AG (Germany)


• Miltenyi Biotec (Germany)


• Becton, Dickinson, and Company (US)


• Cytek Biosciences, Inc. (US)


• Sysmex Corporation (Japan)


• Bio-Rad Laboratories, Inc. (US)


• Luminex Corporation (US)

Flow Cytometry Industry Developments

July 2023:Becton, Dickinson, and Company (US) launched a robotic system to automate clinical flow cytometry. This system prepares samples through flow cytometry for clinical diagnostics which allow for a complete "walkaway" workflow solution in order to improve standardization and reproducibility in cellular diagnostics. It will leverage the clinical flow cytometry diagnostics product portfolio and create an opportunity for the company to generate revenue.

May 2023:Sysmex Corporation SYSMEX CORPORATION (Japan) launched Clinical Flow Cytometry1 System, Flow Cytometer XF-1600, Sample Preparation System PS-10, antibody reagents, and other related products in Japan. Also planning to launch in North America, Europe, and other countries of Asia-Pacific.

February 2023:Bio-Rad Laboratories, Inc (US) launched a new product “StarBright Blue-series and StarBright Yellow-series Dyes”. This provides better flexibility in regular and full spectrum flow cytometry applications.

February 2023:Bio-Rad Laboratories, Inc (US) announced partnership with Cytek Biosciences, Inc. (US) for expanding reagent portfolio. As per the terms of agreement Cytek to exploit and commercialize reagent products to establish high-parameter applications on Aurora and Northern Lights flow cytometry systems.

February 2022:Becton, Dickinson and Company (US) acquired Cytognos (Spain) a company specializing in flow cytometry solutions for blood cancer diagnosis, Minimal Residual Disease (MRD) detection, and immune monitoring research for blood diseases. This acquired accelerated BD’s strategy to support chronic disease management through expanding its portfolio of blood cancer diagnostics.

Flow Cytometry Market Segmentation

Flow Cytometry Component Outlook

• Cytometry Platform
  
  
  
  • Cell Sorters
  
  
  • Cell Analyzers
  
  
  
  


• Accessories
  
  
  
  • Filter
  
  
  • Laser
  
  
  • Detectors
  
  
  • Others
  
  
  
  


• Reagents and Consumables
  
  
  
  • Antibodies
  
  
  • Dyes
  
  
  • Beads
  
  
  • Solution
  
  
  • Buffer
  
  
  • Others
  
  
  
  


• Software


• Services

Flow Cytometry Technology Outlook

• Bead Based Flow Cytometry


• Cell Based Flow Cytometry

Flow Cytometry Application Outlook

• Academic and Clinical Research Applications
  
  
  
  • Cell Cycle Analysis and Cell Proliferation
  
  
  • Apoptosis
  
  
  • Sorting and Screening
  
  
  • Transfection and Cell Viability
  
  
  • Others
  
  
  
  


• Diagnosis Applications
  
  
  
  • Cancer
  
  
  • Leukemia
  
  
  • Lymphoma
  
  
  • Others
  
  
  
  


• Immunodeficiency Diseases
  
  
  
  • Organ Transplantation
  
  
  • Others
  
  
  
  

Flow Cytometry End User Outlook

• Hospitals & Clinics


• Commercial Organizations


• Medical Schools and Clinical Labs


• Research Institutes


• Others

Flow Cytometry Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • India
  
  
  • Japan
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America